Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
156.33
+1.55 (1.00%)
Nov 12, 2026, 2:56 PM EST - Market open

Guardant Health Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
21,14913,1603,7753,2832,78610,168
Market Cap Growth
71.36%248.64%14.96%17.84%-72.60%-21.09%
Enterprise Value
21,81413,9064,1873,4873,0459,850
Last Close Price
154.78102.1430.5527.0527.20100.02

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
16.5413.405.115.826.2027.21
PB Ratio
--132.51-27.0320.6946.3015.76
P/TBV Ratio
---22.4361.6916.20

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
17.0614.165.676.186.7726.36

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-6.13-17.22-9.578.5322.752.13
Net Debt / Equity Ratio
-2.41-5.12-3.551.175.95-0.40
Net Debt / EBITDA Ratio
-1.43-1.28-1.24-0.42-0.700.66
Net Debt / FCF Ratio
-2.86-2.18-1.80-0.54-0.920.91
Asset Turnover
0.810.560.450.330.240.17
Inventory Turnover
4.844.454.364.003.804.60
Quick Ratio
3.254.434.216.115.745.29
Current Ratio
3.604.844.686.546.175.72
Return on Equity (ROE)
---4584.47%-438.12%-185.65%-38.46%
Return on Assets (ROA)
-19.92%-15.58%-16.91%-17.71%-17.84%-11.48%
Return on Capital Employed (ROCE)
-33.30%-25.50%-35.10%-30.40%-38.40%-20.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-2.35%-3.16%-11.56%-14.60%-23.49%-3.99%
FCF Yield
-1.10%-1.77%-7.28%-10.52%-13.89%-2.79%
Buyback Yield / Dilution
-6.19%-2.14%-9.61%-9.60%-0.85%-3.91%
SEC Filings: 10-K · 10-Q